Document:

Prepared by R.R. Donnelley Financial -- Amended & Restated Investor Rights Agreement

  
 Exhibit 4.3 

 
 INVESTORS’ RIGHTS AGREEMENT 
  
 This Investors’ Rights Agreement (this
“Agreement”) is made and entered into as of August 19, 2002 (the “Effective Date” by and among Leadis Technology, Inc., a Delaware corporation (the “Company”) and the persons
and entities listed on Exhibit A attached hereto (the “Investors”). 
  
 A. One of the Investors (the “Series 1 Investor”) is a holder of outstanding shares of the Company’s Series 1 Preferred Stock
(“Series 1 Stock”) issued by the Company to such Series 1 Investor pursuant to a Series 1 Preferred Stock and Common Stock Warrant Purchase Agreement by and among the Company and the Series 1 Investor dated October 6, 2000,
as amended from time to time (the “Series 1 Agreement”). The Series 1 Investor is also the holder of a warrant (the “Warrant”) issued by the Company on October 6, 2000, which is exercisable for 50,000
shares of the Company’s Common Stock (the “Warrant Stock”). 
  
 B. Other Investors (the “Series A Investors”) are holders of outstanding shares of the Company’s Series A Preferred Stock (“Series A Stock”) issued by the Company
to such Series A Investors pursuant, as to certain of the Series A Investors, to a Regulation D Series A Preferred Stock Subscription Agreement between the Company and certain of the Series A Investors (the “Regulation D Series A
Agreement”) and pursuant, as to the remaining Series A Investors, to a Regulation S Series A Preferred Stock Subscription Agreement between the Company and certain of the Series A Investors (the “Regulation S Series A
Agreement”), (such agreements, as amended from time to time, are hereafter collectively referred to as the “Series A Agreements”). 
  
 C. The Series 1 Investor has certain information and registration rights and rights of first refusal under an
Investor’s Rights Agreement between such Series 1 Investor and the Company dated October 6, 2000 (the “Prior Series 1 Rights Agreement”) and the Series A Investors have certain registration rights pursuant to a
Registration Rights Agreement by and among the Company and each of the Series A Investors that was entered into by each of them at the same time as the applicable Series A Agreements (the “Prior Series A Rights Agreement”).

  
 D. Certain Investors (the “Series B
Investors”) have agreed to purchase shares of Series B Stock pursuant to a Series B Preferred Stock Purchase Agreement dated of even date herewith, by and among the Company and such Series B Investors (which agreement, as it may be
amended from time to time hereafter, is referred to as the “Series B Agreement”). The Series B Agreement provides that, as a condition of the obligations of the Series B Investors to consummate the purchase of Series B Stock
thereunder at the initial closing thereunder, the Series B Investors will be granted rights hereunder as “Investors” with respect to the shares of Series B Stock purchased by them. 
  
 E. The Company, the Series 1 Investor and the undersigned Series A Investors
desire to enter into this Agreement in order to amend, restate and replace the rights and obligations under the Prior Series 1 Rights Agreement and the Prior Series A Rights Agreement with the rights and obligations set forth in this Agreement and
to extend the rights and obligations of “Investors” under this Agreement to the Series B Investors upon the initial closing under the Series B Agreement (and any subsequent additional closings thereunder, if any). Section 9 of the 

  

 1. 

 
Prior Series A Rights Agreement provides that the Prior Series A Rights Agreement may be amended by the written consent of the holders of a majority of the
“Registrable Securities” (as defined in Section 1(c) of the Prior Series A Rights Agreement) and the undersigned Series A Investors hold a majority of such Registrable Securities, as defined in that Prior Series A Rights Agreement.

  
 NOW, THEREFORE, in consideration of the
foregoing recitals and the mutual promises hereinafter set forth, the parties hereto agree as follows: 
  

	 	1.	INFORMATION RIGHTS. 

  
 1.1 Financial Information. The Company covenants and agrees that, commencing on the date of this Agreement, for so long as any
Investor holds at least 200,000 shares (or 20,000 shares with respect to Section 1(a)) of Series 1 Stock issued under the Series 1 Agreement, Series A Stock issued under the Series A Agreement, and/or Series B Stock issued under the Series B
Agreement (the shares of Series 1 Stock, Series A Stock and Series B Stock being hereafter sometimes collectively referred to as the “Preferred Stock”) and/or the equivalent numbers (on an as-converted basis) of shares of
Common Stock of the Company (“Common Stock”) issued upon the conversion of such shares of Series 1 Stock, Series A Stock or Series B Stock (“Conversion Stock”) and/or the equivalent numbers of shares
of Warrant Stock, or any combination thereof (each such Investor a “Major Investor”), the Company will: 
  
 (a) Annual Reports. Furnish to such Investor, as soon as practicable and in any event within 90 days after the end of each fiscal
year of the Company, a consolidated Balance Sheet as of the end of such fiscal year, a consolidated Statement of Income and a consolidated Statement of Cash Flows of the Company and its subsidiaries for such year, setting forth in each case in
comparative form the figures from the Company’s previous fiscal year (if any), all prepared in accordance with generally accepted accounting principles and practices and audited by nationally recognized independent certified public accountants,
and a capitalization table in reasonable detail as of the end of such fiscal year; 
  
 (b) Quarterly Reports. Furnish to such Major Investor as soon as practicable, and in any case within 30 days after the end of each
fiscal quarter of the Company (except the last quarter of the Company’s fiscal year), quarterly unaudited financial statements, including an unaudited Balance Sheet, an unaudited Statement of Income and an unaudited Statement of Cash Flows and
a capitalization table in reasonable detail as of the end of such fiscal quarter; 
  
 (c) Monthly Reports. Furnish to such Major Investor as soon as practicable, and in any case within 30 days after the end of each
calendar month (except the last month of each of the Company’s fiscal quarters), monthly unaudited financial statements, including an unaudited Balance Sheet, an unaudited Statement of Income and an unaudited Statement of Cash Flows and a
capitalization table in reasonable detail as of the end of such month; and 
  
 (d) Annual Budget. Furnish to such Major Investor as soon as practicable and in any event no later than 30 days prior to the close of each fiscal year of the 

  

 2. 

 
Company, an annual operating plan and budget, prepared on a monthly basis, for the next immediate fiscal year. 
  
 1.2 Inspection Rights. The Company shall permit each
Major Investor, at such Major Investor’s expense, to visit and inspect the Company’s properties, to examine its books of account and records (including minutes of proceedings and actions of the Company’s Board of Directors and
stockholders) and to discuss the Company’s affairs, finances and accounts with its officers, all at such reasonable times as may be requested by such Major Investor. 
  
 1.3 Confidentiality. Each Investor agrees to hold all information received pursuant to this Section 1
that constitutes nonpublic information, trade secrets of the Company or similar proprietary or confidential information in confidence, and not to use (except for purposes of evaluating its investment in the Company) or disclose any of such
information to any third party, except to the extent such information may be made publicly available by the Company. 
  
 1.4 Termination of Certain Rights. The Company’s obligations under Sections 1.1 and 1.2 above will terminate upon the closing
of the Company’s initial public offering of Common Stock pursuant to an effective registration statement filed under the U.S. Securities Act of 1933, as amended (the “Securities Act”); provided, however,
that the Company shall, after such offering, deliver to Major Investors copies of its quarterly reports on Form 10-Q (or any successor form) filed with the SEC (as defined below) promptly after their filing with the SEC. 
  

	 	2.	REGISTRATION RIGHTS. 

  
 2.1 Definitions. For purposes of this Section 2: 
  
 (a) Registration. The terms “register,”
“registration” and “registered” refer to a registration effected by preparing and filing a registration statement in compliance with the Securities Act, and the declaration or ordering of effectiveness
of such registration statement. 
  
 (b)
Registrable Securities. The term “Registrable Securities” means: (1) all the shares of Common Stock of the Company issued or issuable upon the conversion of any shares of Series 1 Stock issued under the Series 1
Agreement, and/or Series A Stock issued under either of the Series A Agreements, and/or Series B Stock issued under the Series B Agreement, and/or any shares of Warrant Stock and (2) any shares of Common Stock of the Company issued as (or issuable
upon the conversion or exercise of any warrant, right or other security which is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, all such shares of Common Stock described in clause (1) of this
subsection (b); excluding in all cases, however, any Registrable Securities sold by a person in a transaction in which rights under this Section 2 are not assigned in accordance with this Agreement or any Registrable Securities sold to the
public or sold pursuant to Rule 144 promulgated under the Securities Act; provided, however, that notwithstanding anything to the contrary herein, the shares of Series A Stock described in clause (1) of this subsection (b) and any
shares of Common Stock described in clause (2) of this subsection (b) that are issued on account of such Series A Stock (which, together with the shares of Series A Stock, are collectively referred to hereinafter 

  

 3. 

 
as the “Excluded Shares”), shall not be “Registrable Securities” for purposes of Sections 2.2, 2.4, 3 or 4.2 of this
Agreement. 
  
 (c) Registrable Securities Then
Outstanding. The number of shares of “Registrable Securities then outstanding” shall mean the number of shares of Common Stock which are Registrable Securities and (1) are then issued and outstanding, or (2) are then
issuable pursuant to the exercise or conversion of then outstanding and then exercisable options, warrants or convertible securities. 
  
 (d) Holder. For purposes of Sections 2, 3 and 4, the term “Holder” means any person owning of record
Registrable Securities or any assignee of record of such Registrable Securities to whom rights under such Sections have been duly assigned in accordance with this Agreement; provided, however, that for purposes of this Agreement, a
record holder of shares of Series 1 Stock, Series A Stock, or Series B Stock convertible into such Registrable Securities shall be deemed to be the Holder of such Registrable Securities; and provided, further, that for purposes of
Sections 2 and 4 (but not Section 3), a record holder of the Warrant shall be deemed to be the Holder of the Registrable Securities issuable upon exercise thereof, and provided, further, that the Company shall in no event be obligated
to register shares of Series 1 Stock, Series A Stock, Series B Stock, or the Warrant and that Holders of Registrable Securities will not be required to convert their shares of Series 1 Stock, Series A Stock, or Series B Stock into Common Stock, or
to exercise the Warrant, in order to exercise the registration rights granted hereunder, until immediately before the closing of the offering to which the registration relates. An Investor holding Registrable Securities that are Excluded Shares
shall not be deemed a “Holder” with respect thereto for purposes Sections 2.2, 2.4, 3 or 4.2. 
  
 (e) Form S-3. The term “Form S-3” means such form under the Securities Act as is in effect on the date
hereof or any successor registration form under the Securities Act subsequently adopted by the SEC which permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC. 
  
 (f) SEC. The term “SEC” or
“Commission” means the U.S. Securities and Exchange Commission. 
  
 2.2 Demand Registration. 
  
 (a) Request by Holders. If the Company shall receive at any time after the earlier of August 19, 2005, or six (6) months
after the effective date of the Company’s initial public offering of its securities pursuant to a registration filed under the Securities Act (an “IPO”), a written request from the Holders of at least thirty percent
(30%) of the Registrable Securities then outstanding that the Company file a registration statement under the Securities Act covering the registration of Registrable Securities pursuant to this Section 2.2, then the Company shall, within thirty (30)
days after the receipt of such written request, give written notice of such request (“Request Notice”) to all Holders, and effect, as soon as practicable, the registration under the Securities Act of all Registrable
Securities which Holders request to be registered and included in such registration by written notice given by such Holders to the Company within twenty (20) days after receipt of the Request Notice, subject only to the limitations of this Section
2; provided, however, that the Registrable Securities requested by all 

  

 4. 

 
Holders to be registered pursuant to such request must either (i) be at least twenty percent (20%) of all Registrable Securities then outstanding that are
then held by the Holders requesting to include Registrable Securities in such registration, or (ii) have an anticipated aggregate public offering price (before any underwriting discounts and commissions) of not less than Ten Million Dollars
($10,000,000). 
  
 (b) Underwriting. If
the Holders initiating the registration request under this Section 2.2 (“Initiating Holders”) intend to distribute the Registrable Securities covered by their request by means of an underwriting, then they shall so advise the
Company as a part of their request made pursuant to this Section 2.2 and the Company shall include such information in the Request Notice. In such event, the right of any Holder to include his Registrable Securities in such registration shall be
conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting (unless otherwise mutually agreed by a majority in interest of the Initiating Holders and such
Holder) to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall enter into an underwriting agreement in customary form with the managing underwriter or underwriters selected for such
underwriting by the Company and reasonably acceptable to the Initiating Holders who hold a majority of the Registrable Securities then Outstanding held by all Initiating Holders. Notwithstanding any other provision of this Section 2.2, if the
underwriter(s) advise(s) the Company in writing that marketing factors require a limitation of the number of securities to be underwritten, then the Company shall so advise all Holders of Registrable Securities that would otherwise be registered and
underwritten pursuant hereto, and the number of Registrable Securities that may be included in the underwriting shall be reduced as required by the underwriter(s) and allocated among the Holders of Registrable Securities on a pro rata basis
according to the number of Registrable Securities then outstanding held by each Holder requesting registration (including the Initiating Holders); provided, however, that the number of shares of Registrable Securities to be included in
such underwriting and registration shall not be reduced unless all other securities of the Company and securities held by any employee or former employee of the Company are first entirely excluded from the underwriting and registration. Any
Registrable Securities excluded and withdrawn from such underwriting shall be withdrawn from the registration. 
  
 (c) Maximum Number of Demand Registrations. The Company is obligated to effect only two (2) such registrations pursuant to this
Section 2.2; provided, however, that a registration shall only be deemed to have been “effected” hereunder if the relevant registration statement is declared or deemed to be effective. 
  
 (d) Deferral. Notwithstanding the foregoing, if the
Company shall furnish to Holders requesting the filing of a registration statement pursuant to this Section 2.2, a certificate signed by the President or Chief Executive Officer of the Company stating that in the good faith judgment of the Board of
Directors of the Company, it would be seriously detrimental to the Company and its stockholders for such registration statement to be filed and it is therefore essential to defer the filing of such registration statement, then the Company shall have
the right to defer such filing for a period of not more than 120 days after receipt of the request of the Initiating Holders; provided, however, that the Company may not utilize this right more than once in any twelve (12) month
period. Notwithstanding anything to the contrary herein, the Company shall not be obligated to effect a demand registration under this Section 2.2 during the 

  

 5. 

 
period beginning on the date that is ninety (90) days prior to the Company’s good faith estimate of the date on which it intends to file a registration
statement for its IPO and ending one hundred and eighty (180) days after the effective date of its IPO if, within thirty (30) days of receipt of a written request for a demand registration under this Section 2.2 from the Initiating Holders, the
Company delivers written notice to such Initiating Holders of its intent to file a registration statement for its IPO within ninety (90) days. 
  
 (e) Expenses. All expenses incurred in connection with a registration pursuant to this Section 2.2, including without limitation
all registration and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the Company, and the reasonable fees and disbursements of one counsel for the selling Holders (but excluding underwriters’
discounts and commissions), shall be borne by the Company. Each Holder participating in a registration pursuant to this Section 2.2 shall bear such Holder’s proportionate share (based on the total number of shares sold in such registration
other than for the account of the Company) of all discounts, commissions or other amounts payable to underwriters or brokers in connection with such offering. Notwithstanding the foregoing, the Company shall not be required to pay for any expenses
of any registration proceeding begun pursuant to this Section 2.2 if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered, unless the Holders of a majority of
the Registrable Securities then outstanding agree to forfeit their right to one (1) demand registration pursuant to this Section 2.2 (in which case such right shall be forfeited by all Holders of Registrable Securities); provided,
however, that if at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business, or prospects of the Company not known to the Holders at the time of their request for such registration and
have withdrawn their request for registration with reasonable promptness after learning of such material adverse change, then the Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to this Section 2.2.

  
 2.3 Piggyback Registrations. The
Company shall notify all Holders of Registrable Securities in writing at least thirty (30) days prior to filing any registration statement under the Securities Act for purposes of effecting a public offering of securities of the Company (including,
but not limited to, registration statements relating to secondary offerings of securities of the Company, but excluding registration statements relating to any registration under Section 2.2 or Section 2.4 of this Agreement or to any employee
benefit plan or a corporate reorganization) and will afford each such Holder an opportunity to include in such registration statement all or any part of the Registrable Securities then held by such Holder. Each Holder desiring to include in any such
registration statement all or any part of the Registrable Securities held by such Holder shall, within twenty (20) days after receipt of the above-described notice from the Company, so notify the Company in writing, and in such notice shall inform
the Company of the number of Registrable Securities such Holder wishes to include in such registration statement. If a Holder decides not to include all of its Registrable Securities in any registration statement thereafter filed by the Company,
such Holder shall nevertheless continue to have the right to include any Registrable Securities in any subsequent registration statement or registration statements as may be filed by the Company with respect to offerings of its securities, all upon
the terms and conditions set forth herein. 
  

 6. 

 (a) Underwriting. If a registration statement under which the Company gives notice
under this Section 2.3 is for an underwritten offering, then the Company shall so advise the Holders of Registrable Securities. In such event, the right of any such Holder’s Registrable Securities to be included in a registration pursuant to
this Section 2.3 shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute
their Registrable Securities through such underwriting shall enter into an underwriting agreement in customary form with the managing underwriter or
 underwriter(s) selected for such underwriting. Notwithstanding any other provision of this
Agreement, if the managing underwriter(s) determine(s) in good faith that marketing factors require a limitation of the number of shares to be underwritten, then the managing underwriter(s) may exclude shares (including Registrable Securities) from
the registration and the underwriting, and the number of shares that may be included in the registration and the underwriting shall be allocated, first, to the Company, second, to each of the Holders requesting inclusion of their
Registrable Securities in such registration statement on a pro rata basis based on the total number of Registrable Securities then held by each such Holder, and third to any employee or former employee of the Company, if applicable;
provided, however, that the right of the underwriters to exclude shares (including Registrable Securities) from the registration and underwriting as described above shall be restricted so that the number of Registrable Securities
included in any such registration is not reduced below thirty percent (30%) of the shares included in the registration, except for a registration relating to the Company’s initial public offering from which all Registrable Securities may
be excluded if no shares of any other selling stockholder are included therein. If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to the Company and the underwriter,
delivered at least twenty (20) days prior to the effective date of the registration statement. Any Registrable Securities excluded or withdrawn from such underwriting shall be excluded and withdrawn from the registration. For any Holder that is a
partnership, limited liability company or corporation, the partners, retired partners, members, retired members and stockholders of such Holder, or the estates and family members of any such partners, retired partners, members and retired members
and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single “Holder,” and any pro rata reduction with respect to such “Holder” shall be based upon the aggregate amount of shares carrying
registration rights owned by all entities and individuals included in such “Holder,” as defined in this sentence. 
  
 (b) Expenses. All expenses incurred in connection with each registration pursuant to this Section 2.3 (excluding underwriters’
and brokers’ discounts and commissions), including, without limitation all federal and “blue sky” registration and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the Company and
reasonable fees and disbursements of one counsel for the selling Holders shall be borne by the Company. 
  
 2.4 Form S-3 Registration. In case the Company shall receive from any Holder or Holders of at least five percent (5%) of the
Registrable Securities then outstanding a written request or requests that the Company effect a registration on Form S-3 and any related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder or
Holders, then the Company will: 
  
 (a)
Notice. Promptly give written notice of the proposed registration and the Holder’s or Holders’ request therefor, and any related qualification or compliance, to all other Holders of Registrable Securities; and 
  

 7. 

 (b) Registration. As soon as practicable, effect such registration and all such
qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holder’s or Holders’ Registrable Securities as are specified in such request, together with
all or such portion of the Registrable Securities of any other Holder or Holders joining in such request as are specified in a written request given within twenty (20) days after receipt of such written notice from the Company; provided,
however, that the Company shall not be obligated to effect any such registration, qualification or compliance pursuant to this Section 2.4; 
  
 (1) if Form S-3 is not available for such offering; 
  
 (2) if the Holders, together with the holders of any other securities of the Company entitled to inclusion
in such registration, propose to sell Registrable Securities and such other securities (if any) at an aggregate price to the public of less than One Million Dollars ($1,000,000); 
  
 (3) if the Company shall furnish to the Holders a certificate signed by the President or Chief Executive
Officer of the Company stating that in the good faith judgment of the Board of Directors of the Company, it would be seriously detrimental to the Company and its stockholders for such Form S-3 Registration to be effected at such time, in which event
the Company shall have the right to defer the filing of the Form S-3 registration statement no more than once during any twelve month period for a period of not more than 120 days after receipt of the request of the Holder or Holders under this
Section 2.4; 
  
 (4) if the Company has, within
the twelve (12) month period preceding the date of such request, already effected two (2) registrations on Form S-3 for the Holders pursuant to this Section 2.4; or 
  
 (5) in any particular jurisdiction in which the Company would be required to qualify to do business or to
execute a general consent to service of process in effecting such registration, qualification or compliance. 
  
 (c) Expenses. Subject to the foregoing, the Company shall file a Form S-3 registration statement covering the Registrable
Securities and other securities so requested to be registered pursuant to this Section 2.4 as soon as practicable after receipt of the request or requests of the Holders for such registration. The Company shall pay all expenses incurred in
connection with registrations requested pursuant to this Section 2.4, (excluding underwriters’ or brokers’ discounts and commissions), including without limitation all filing, registration and qualification, printers’ and accounting
fees and the reasonable fees and disbursements of one counsel for the selling Holder or Holders and counsel for the Company. 
  
 (d) Not A Demand Registration. Form S-3 registrations shall not be deemed to be demand registrations as described in Section 2.2
above. 
  

 8. 

 2.5 Obligations of the Company. Whenever required to effect the registration of
any Registrable Securities under this Agreement, the Company shall, as expeditiously as reasonably possible: 
  
 (a) Prepare and file with the SEC a registration statement with respect to such Registrable Securities and use reasonable, diligent
efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective for up to ninety (90) days.

  
 (b) Prepare and file with the SEC such
amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all
securities covered by such registration statement. 
  
 (c) Furnish to the Holders such number of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate
the disposition of the Registrable Securities owned by them that are included in such registration. 
  
 (d) Use reasonable, diligent efforts to register and qualify the securities covered by such registration statement under such other
securities or blue sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided, however, that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or
to file a general consent to service of process in any such states or jurisdictions. 
  
 (e) In the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and
customary form, with the managing underwriter(s) of such offering. Each Holder participating in such underwriting shall also enter into and perform its obligations under such an agreement. 
  
 (f) Notify each Holder of Registrable Securities covered by
such registration statement at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing. 
  
 (g) Furnish, at the request of any Holder requesting
registration of Registrable Securities, on the date that such Registrable Securities are delivered to the underwriters for sale, if such securities are being sold through underwriters, or, if such securities are not being sold through underwriters,
on the date that the registration statement with respect to such securities becomes effective, (1) an opinion, dated as of such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is
customarily given to underwriters in an underwritten public offering, addressed to the underwriters, if any, and to the Holders requesting registration of Registrable Securities and (2) a “comfort” letter dated as of such date, from the
independent certified public accountants of the 

  

 9. 

 
Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering and
reasonably satisfactory to a majority in interest of the Holders requesting registration, addressed to the underwriters, if any, and to the Holders requesting registration of Registrable Securities. 
  
 2.6 Furnish Information. It shall be a condition
precedent to the obligations of the Company to take any action pursuant to Sections 2.2, 2.3 or 2.4 that the selling Holders shall furnish to the Company such information regarding themselves, the Registrable Securities held by them, and the
intended method of disposition of such securities as shall be required to timely effect the registration of their Registrable Securities. 
  
 2.7 Delay of Registration. No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any
such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 
  
 2.8 Indemnification. In the event any Registrable Securities are included in a registration statement under Sections 2.2, 2.3 or
2.4: 
  
 (a) By the Company. To the extent
permitted by law, the Company will indemnify and hold harmless each Holder, the partners, members, officers and directors of each Holder, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such
Holder or underwriter within the meaning of the Securities Act or the Securities Exchange Act of 1934, as amended, (the “1934 Act”), against any losses, claims, damages, or liabilities (joint or several) to which they may
become subject under the Securities Act, the 1934 Act or other federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements omissions or
violations (collectively, “Violations” and, individually, a “Violation”): 
  
 (1) any untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any
preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto; 
  
 (2) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements
therein not misleading, or 
  
 (3) any violation
or alleged violation by the Company of the Securities Act, the 1934 Act, any federal or state securities law or any rule or regulation promulgated under the Securities Act, the 1934 Act or any federal or state securities law in connection with the
offering covered by such registration statement; 
  
 and the
Company will reimburse each such Holder, partner, member, officer or director, underwriter or controlling person for any legal or other expenses reasonably incurred by them, as incurred, in connection with investigating or defending any such loss,
claim, damage, liability or action; provided, however, that the indemnity agreement contained in this subsection 2.8(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such
settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of
or is based upon a Violation 

  

 10. 

 
which occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such registration by such Holder,
partner, member, officer, director, underwriter or controlling person. 
  
 (b) By Selling Holders. To the extent permitted by law, each selling Holder will indemnify and hold harmless the Company, each of its directors, each of its officers who have signed the registration statement,
each person, if any, who controls the Company within the meaning of the Securities Act, any underwriter and any other Holder selling securities under such registration statement or any of such other Holder’s partners, members, directors or
officers or any person who controls such Holder within the meaning of the Securities Act or the 1934 Act, against any losses, claims, damages or liabilities (joint or several) to which the Company or any such director, officer, controlling person,
underwriter or other such Holder, partner, member, or director, officer or controlling person of such other Holder may become subject under the Securities Act, the 1934 Act or other federal or state law, insofar as such losses, claims, damages or
liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such
Holder expressly for use in connection with such registration; and each such Holder will reimburse any legal or other expenses reasonably incurred by the Company or any such director, officer, controlling person, underwriter or other Holder,
partner, member, officer, director or controlling person of such other Holder in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained in
this subsection 2.8(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld; and
provided further, that the total amounts payable in indemnity by a Holder under this Section 2.8(b) in respect of any Violation shall not exceed the net proceeds received by such Holder in the registered offering out of which such
Violation arises. 
  
 (c) Notice. Promptly
after receipt by an indemnified party under this Section 2.8 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party
under this Section 2.8, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other
indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party shall have the right to retain its own counsel, with the reasonable
fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential conflict of interests between such indemnified
party and any other party represented by such counsel in such proceeding; provided, further, however, that where there are multiple indemnified parties, the indemnifying party shall only pay the reasonable fees and expenses of
one (1) such separate counsel for all of the indemnified parties. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if and to the extent prejudicial to its ability to
defend such action, shall relieve such indemnifying party of any liability to the indemnified party under this Section 2.8, but the omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it may have
to any indemnified party otherwise than under this Section 2.8. 
  

 11. 

 (d) Defect Eliminated in Final Prospectus. The foregoing indemnity agreements of
the Company and Holders are subject to the condition that, insofar as they relate to any Violation made in a preliminary prospectus but eliminated or remedied in the amended prospectus on file with the SEC at the time the registration statement in
question becomes effective or the amended prospectus filed with the SEC pursuant to SEC Rule 424(b) (the “Final Prospectus”), such indemnity agreement shall not inure to the benefit of any person if a copy of the Final
Prospectus was furnished to the indemnified party and was not furnished to the person asserting the loss, liability, claim or damage at or prior to the time such action is required by the Securities Act. 
  
 (e) Contribution. In order to provide for just and
equitable contribution to joint liability under the Securities Act in any case in which either (1) any Holder exercising rights under this Agreement, or any partner, member, director, officer or controlling person of any such Holder, makes a claim
for indemnification pursuant to this Section 2.8 but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that
such indemnification may not be enforced in such case notwithstanding the fact that this Section 2.8 provides for indemnification in such case, or (2) contribution under the Securities Act may be required on the part of any such selling Holder, or
any partner, member, director, officer or controlling person of such Holder in circumstances for which indemnification is provided under this Section 2.8; then, and in each such case, the Company and such Holder or partner, member, director, officer
or controlling person of such Holder will contribute to the aggregate losses, claims, damages or liabilities to which they may be subject (after contribution from others) in such proportion so that such Holder or partner, member, director, officer
or controlling person of such Holder is responsible for the portion represented by the percentage that the public offering price of such Holder’s Registrable Securities offered by and sold under the registration statement bears to the public
offering price of all securities offered by and sold under such registration statement, and the Company and other selling Holders are responsible for the remaining portion; provided, however, that, in any such case, (A) no such Holder
or partner, member, director, officer or controlling person of such Holder will be required to contribute any amount in excess of the public offering price of all such Registrable Securities offered and sold by such Holder pursuant to such
registration statement net of underwriters’ discounts and commissions; and (B) no person or entity guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any
person or entity who was not guilty of such fraudulent misrepresentation. 
  
 (f) Survival. The obligations of the Company and Holders under this Section 2.8 shall survive the completion of any offering of Registrable Securities in a registration statement, and otherwise. 
  
 2.9 “Market Stand-Off” Agreement. Each
Holder hereby agrees that it shall not, to the extent requested by the Company or an underwriter of securities of the Company, sell or otherwise transfer or dispose of any Registrable Securities or other shares of stock of the Company then owned by
such Holder (other than to donees or partners, sole stockholders, or parent corporations of the Holder who agree to be similarly bound) for up to one hundred eighty (180) days following the effective date of a registration statement of the Company
filed under the Securities Act; provided, however, that: 
  
 (a) such agreement shall be applicable only to the first such registration statement of the Company which covers securities to be sold on its behalf to the public in an underwritten offering but not to Registrable
Securities sold pursuant to such registration statement; and 
  

 12. 

 (b) restrictions contained in this Section 2.9 shall not apply unless all officers and
directors of the Company and all persons holding more than one percent (1%) of the Company’s outstanding voting securities are each bound by similar “lockup” provisions as of the time of such registration. 
  
 In order to enforce the foregoing covenant, the Company shall have the right
to place restrictive legends on the certificates representing the shares subject to this Section and to impose stop transfer instructions with respect to the Registrable Securities and such other shares of stock of each Holder (and the shares or
securities of every other person subject to the foregoing restriction) until the end of such period. 
  
 2.10 Rule 144 Reporting. With a view to making available the benefits of certain rules and regulations of the Commission which may
at any time permit the sale of the Registrable Securities to the public without registration, after such time as a public market exists for the Common Stock of the Company, the Company agrees to: 
  
 (a) Make and keep public information available, as those
terms are understood and defined in Rule 144 under the Securities Act, at all times after the effective date of the first registration under the Securities Act filed by the Company for an offering of its securities to the general public; 

 
 (b) Use reasonable, diligent efforts to file with the
Commission in a timely manner all reports and other documents required of the Company under the Securities Act and the 1934 Act (at any time after it has become subject to such reporting requirements); and 
  
 (c) So long as a Holder owns any Registrable Securities, to
furnish to the Holder forthwith upon request a written statement by the Company as to its compliance with the reporting requirements of said Rule 144 (at any time after 90 days after the effective date of the first registration statement filed by
the Company for an offering of its securities to the general public), and of the Securities Act and the 1934 Act (at any time after it has become subject to the reporting requirements of the 1934 Act), a copy of the most recent annual or quarterly
report of the Company, and such other reports and documents of the Company as a Holder may reasonably request in availing itself of any rule or regulation of the Commission allowing a Holder to sell any such securities without registration (at any
time after the Company has become subject to the reporting requirements of the 1934 Act). 
  
 2.11 Termination of the Company’s Obligations. The Company shall have no obligations pursuant to Sections 2.2, 2.3 or 2.4 with
respect to any Registrable Securities proposed to be sold by a Holder in a registration pursuant to Sections 2.2, 2.3 or 2.4 following the Company’s initial public offering if, in the opinion of counsel to the Company, all such Registrable
Securities proposed to be sold by a Holder may be sold in a three month period pursuant to Rule 144 under the Securities Act. Without limiting the foregoing provisions of this 

  

 13. 

 
Section 2.11, the Company shall have no obligation to effect any registration of Registrable Securities under Sections 2.2, 2.3 or 2.4 after the fifth (5th)
anniversary of an IPO; provided however, that if any shares of Series B Stock are outstanding immediately prior to the closing of such IPO, then such IPO shall trigger the running of the foregoing five (5) year period only if all
outstanding shares of Series B Stock are automatically converted to Common Stock in connection with such IPO. 
  

	 	3.	RIGHT OF FIRST REFUSAL. 

  
 3.1 General. Each Holder (as defined in Section 2.1(d)) and any party to whom such Holder’s rights under this Section 3 have
been duly assigned in accordance with Section 4.1(b) (each such Holder or assignee being hereinafter referred to as a “Rights Holder”) has the right of first refusal to purchase such Rights Holder’s Pro Rata Share (as
defined below), of all (or any part) of any “New Securities” (as defined in Section 3.2) that the Company may from time to time issue after the Effective Date; provided, however, that the term “Rights Holder” shall
not include any person who does not, at the time in question, qualify as an “accredited investor” (as that term is defined in Regulation D promulgated under the Securities Act). A Rights Holder’s “Pro Rata
Share” for purposes of this right of first refusal is the ratio of (a) the number of Registrable Securities as to which such Rights Holder is the Holder (and/or is deemed to be the Holder under Section 2.1(d)), to (b) a number of shares
of Common Stock of the Company equal to the sum of (1) the total number of shares of Common Stock of the Company then outstanding plus (2) the total number of shares of Common Stock of the Company into which all then outstanding shares of Preferred
Stock of the Company are then convertible plus (3) the number of shares of Common Stock of the Company reserved for issuance upon exercise of then outstanding options and warrants. 
  
 3.2 New Securities. “New Securities” shall mean any Common Stock or preferred
stock of the Company, whether now authorized or not, and rights, options or warrants to purchase such Common Stock or preferred stock, and securities of any type whatsoever that are, or may become, convertible or exchangeable into such Common Stock
or preferred stock; provided, however, that the term “New Securities” does not include: 
  
 (a) shares of Common Stock (or options or rights therefor) granted or issued on or after the Effective Date to employees, officers,
directors, contractors, consultants or advisers to, the Company (or to any other corporation of which at least 50% of the outstanding voting stock is at the time owned directly or indirectly by the Company or by one or more of such subsidiary
corporations (each a “Subsidiary”)) pursuant awards or grants made under the Company’s 2000 Stock Incentive Plan or 2002 Equity Incentive Plan and shares of Common Stock issuable upon exercise of any such awards or
grants which are options or rights to acquire Common Stock; 
  
 (b) shares of Common Stock issuable upon exercise of options, warrants, or rights that are outstanding as of the Effective Date; 
  
 (c) shares of capital stock of the Company (and/or options or warrants therefor) granted or issued after the
Effective Date to financial institutions in connection with equipment financing arrangements that are approved by the Board of Directors, including the 

  

 14. 

 
approval of at least one of the two directors elected by the holders of Series B Stock, voting as a separate class (the “Series B
Directors”); 
  
 (d) shares of
capital stock of the Company (and/or options or warrants therefor) granted or issued after the Effective Date to consultants to, or customers or strategic partners of, the Company (or any Subsidiary), or parties providing the Company (or any
Subsidiary) with bona fide recruiting fees, real property leases, strategic partnering arrangements, licensing arrangements, asset purchases, loans, credit lines, guaranties of indebtedness, cash price reductions or similar financing, or similar
transactions under arrangements approved by the Board of Directors, including the approval of both of the Series B Directors; 
  
 (e) shares of capital stock of the Company (and/or options or warrants therefore) issued or issuable in connection with any stock splits,
combinations, dividends, distributions or similar events; 
  
 (f) shares of capital stock of the Company (and/or options or warrants therefor) issued pursuant to the acquisition of another corporation or entity by the Company (or any Subsidiary) by consolidation, merger,
purchase of all or substantially all of the assets, or other reorganization in which the Company (or any Subsidiary) acquires, in a single transaction or series of related transactions, all or substantially all of the assets of such other
corporation or entity or fifty percent (50%) or more of the voting power of such other corporation or entity or fifty percent (50%) or more of the equity ownership of such other entity, which acquisition is approved by the Board of Directors,
including the approval of both of the Series B Directors; 
  
 (g) shares of Common Stock issued or issuable upon conversion of the outstanding shares of the Preferred Stock; and 
  
 (h) securities offered by the Company to the public in the IPO. 
  
 3.3 Procedures. In the event that the Company proposes to undertake an issuance of New Securities, it
shall give to each Rights Holder written notice of its intention to issue New Securities (the “Notice”), describing the type of New Securities and the price and the general terms upon which the Company proposes to issue such
New Securities. Each Rights Holder shall have twenty (20) days from the date of mailing of any such Notice to agree in writing to purchase such Rights Holder’s Pro Rata Share of such New Securities for the price and upon the general terms
specified in the Notice by giving written notice to the Company and stating therein the quantity of New Securities to be purchased (not to exceed such Rights Holder’s Pro Rata Share). If any Rights Holder fails to so agree in writing within
such twenty (20) day period to purchase such Rights Holder’s full Pro Rata Share of an offering of New Securities (a “Nonpurchasing Holder”), then such Nonpurchasing Holder shall forfeit the right hereunder to purchase
that part of his Pro Rata Share of such New Securities that he did not so agree to purchase and the Company shall promptly give each Rights Holder who has timely agreed to purchase his full Pro Rata Share of such offering of New Securities (a
“Purchasing Holder”) written notice of the failure of any Nonpurchasing Holder to purchase such Nonpurchasing Rights Holder’s full Pro Rata Share of such offering of New Securities (the “Overallotment
Notice”). Each Purchasing Holder shall have a right of overallotment such that 

  

 15. 

 
such Purchasing Holder may agree to purchase a portion of the Nonpurchasing Holders’ unpurchased Pro Rata Shares of such offering on a pro rata basis
according to the relative Pro Rata Shares of the Purchasing Rights Holders, at any time within five (5) days after receiving the Overallotment Notice. 
  
 3.4 Failure to Exercise. In the event that the Rights Holders fail to exercise in full the right of first refusal within such
twenty (20) plus five (5) day period, then the Company shall have 120 days thereafter to sell the New Securities with respect to which the Rights Holders’ rights of first refusal hereunder were not exercised, at a price and upon general terms
not materially more favorable to the purchasers thereof than specified in the Company’s Notice to the Rights Holders. In the event that the Company has not issued and sold the New Securities within such 120 day period, then the Company shall
not thereafter issue or sell any New Securities without again first offering such New Securities to the Rights Holders pursuant to this Section 3. 
  
 3.5 Termination. This right of first refusal shall terminate (a) immediately before the closing of the IPO, or (b) upon (1) the
acquisition of all or substantially all the assets of the Company or (2) an acquisition of the Company by another corporation or entity by consolidation, merger or other reorganization in which the holders of the Company’s outstanding voting
stock immediately prior to such transaction own, immediately after such transaction, securities representing less than fifty percent (50%) or more of the voting power of the corporation or other entity surviving such transaction. 
  

	 	4.	ASSIGNMENT AND AMENDMENT. 

  
 4.1 Assignment. Notwithstanding anything herein to the contrary: 
  
 (a) Information Rights. The rights of an Investor under Section 1.1 or 1.2 hereof may be assigned
only to a party who acquires from an Investor (or an Investor’s permitted assigns) at least that number of shares of Series 1 Stock, Series A Stock, or Series B Stock and/or equivalent numbers (on an as converted basis) of shares of Conversion
Stock and/or shares of Warrant Stock necessary to receive the rights described in Section 1.1 or 1.2 hereof, respectively. Any assignment of rights hereunder shall be contingent upon the transferee agreeing in a writing satisfactory to the Company
to be bound by the terms and conditions of this Agreement as an “Investor” hereunder. 
  
 (b) Registration Rights; Refusal Rights. The registration rights of a Holder under Section 2 hereof and the rights of first refusal
of a Rights Holder under Section 3 hereof may be assigned only to (i) a party who acquires a number of shares of Series 1 Stock, Series A Stock and/or Series B Stock, and/or equivalent numbers (on an as converted basis) of Registrable Securities
and/or of shares of Warrant Stock equal to at least twenty percent (20%) of the total number of such shares (calculated on an as converted basis) originally held by the applicable Investor who first held those shares as of the Effective Date, or
(ii) to a party who is an “affiliate” (as defined in Regulation D promulgated under the Securities Act) of such Holder or Rights Holder; provided, however that no party may be assigned any of the foregoing rights unless the
Company is given written notice by the assigning party at the time of such assignment stating the name and address of the assignee and identifying the securities of the Company as to 

  

 16. 

 
which the rights in question are being assigned; and provided, further, that any such assignee shall receive such assigned rights subject to
all the terms and conditions of this Agreement, including without limitation the provisions of this Section 4. Any assignment of rights hereunder shall be contingent upon the transferee agreeing in a writing satisfactory to the Company to be bound
by the terms and conditions of this Agreement as an “Investor” hereunder. 
  
 4.2 Amendment of Rights. Any provision of this Agreement may be amended and the observance thereof may be waived (either generally
or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and Holders of a majority of the Registrable Securities then outstanding; provided, however, that the
“piggyback” registration rights granted to the holders of Excluded Shares as expressly set forth under Section 2.3 of this Agreement may not be materially and adversely changed in a manner different from the corresponding express rights of
the other Investors thereunder without the written consent of the holders of Excluded Shares holding a majority of the Excluded Shares; and provided, further, however, that the rights of the USVP Affiliated Investors (as defined
below) and the Walden International Affiliated Investors (as defined below) set forth in Section 5.2 may not be amended or waived without the express written consent of the Majority USVP Affiliated Investors (as defined below) and the Majority
Walden International Affiliated Investors (as defined below), respectively. Any amendment or waiver effected in accordance with this Section 4.2 shall be binding upon each Investor, each other Holder, and each permitted successor or assignee of such
Investor or Holder and the Company. 
  
 4.3
New Investors. 
  
 (a) Additional
Closings of Series B Financing. Notwithstanding anything herein to the contrary, if pursuant to Section 2.2 (or any similar provision) of the Series B Agreement, additional parties purchase shares of Series B Stock in additional closings, if
any, as “New Investors” thereunder after the Effective Date, then each such New Investor shall become a party to this Agreement as an “Investor” hereunder, without the need for any consent, approval or signature of any Investor
when such New Investor has both: (a) purchased shares of Series B Stock under the Series B Agreement, and paid the Company all consideration payable for such shares and (b) executed one or more counterpart signature pages to this Agreement as an
“Investor,” with the Company’s consent. 
  
 (b) Other Matters. Exhibit A shall be amended at each additional closing in which shares of Series B Stock are sold to “New Investors” under the Series B Agreement, if any, to add each new Investor who becomes a party
hereto pursuant to this Section 4.3 at each such closing, and/or issuance, and/or distribution. 
  

	 	5.	ADDITIONAL COVENANT. 

  
 5.1 Limitations on Subsequent Registration Rights. The Company shall not enter into any agreement granting any holder or
prospective holder of any securities of the Company registration rights equal or superior to the rights granted hereunder without the prior written consent of the Holders of a majority of the Registrable Securities then outstanding. 
  

 17. 

 5.2 Registration Outside the United States. Any registration of the Company’s
shares of capital stock under the laws of any nation other than the United States for purposes of making a public offering of the Company’s capital stock in such other nation and creating a public market for the Company’s capital stock in
such other nation shall be subject to the express prior written approval of each of (i) the Holders of a majority of the Registrable Securities then outstanding that are held, in the aggregate, by the USVP Affiliated Investors (as defined below)
(the “Majority USVP Affiliated Investors”), and (ii) the Holders of a majority of the Registrable Securities then outstanding that are held, in the aggregate, by the Walden International Affiliated Investors (as defined
below) (the “Majority Walden International Affiliated Investors”), which approval may be withheld in their sole discretion, for any reason. “USVP Affiliated Investors” means those Investors affiliated
with US Venture Partners as designated on Exhibit A attached hereto (and their permitted successors and assigns). “Walden International Affiliated Investors” means those Investors affiliated with Walden International
as designated on Exhibit A attached hereto (and their permitted successors and assigns). Notwithstanding the foregoing, the USVP Affiliated Investors shall have no rights under this Section 5.2 if they cease to be Holders of a number of
Registrable Securities then outstanding equal to less than thirty percent (30%) of the total number of Registrable Securities then outstanding as to which they were Holders on the day immediately following the Effective Date, and the Walden
International Affiliated Investors shall have no rights under this Section 5.2 if they cease to be the Holders of a number of Registrable Securities then outstanding equal to less than thirty percent (30%) of the total number of Registrable
Securities then outstanding as to which they were Holders on the day immediately following the Effective Date, in each case as such numbers may be adjusted pursuant to Section 6.10. This Section 5.2 shall terminate at the same time that the right of
first refusal in Section 3 terminates in accordance with the terms and conditions of Section 3.5. 
  
 5.3 Vesting; Other Restrictions. During the period beginning immediately following the Effective Date and ending on the closing of
the IPO, the Company shall not, without the consent of either (i) both of the Series B Directors or (ii) the Holders of a majority of the Registrable Securities then outstanding, do any of the following: 
  
 (a) issue incentive options or stock awards under the
Company’s 2002 Equity Incentive Plan (or any other employee equity incentive plan that may be adopted by the Company) to employees of the Company (“Awards”) that do not provide for vesting (which terminates upon
termination of employment or consulting relationship with the Company) over a period of at least four (4) years, beginning on a date that is no earlier than such employee’s first date of employment by the Company, with no more than 25% vesting
on the first anniversary of such beginning date and the balance vesting no faster than in thirty-six (36) equal monthly increments thereafter; 
  
 (b) Issue Awards providing for a repurchase of unvested shares of capital stock at a price higher than the original exercise price paid by
the stockholder for such shares, or permitting transfers of unvested shares; 
  
 (c) Issue Awards that do not provide for a Company right of first refusal to acquire vested shares proposed to be transferred by the holder thereof (subject to customary exceptions for transfers to family members or
for tax planning purposes); 
  

 18. 

 (d) Issue any additional incentive options or stock awards under the Company’s 2000
Stock Incentive Plan. 
  

	 	6.	GENERAL PROVISIONS. 

  
 6.1 Notices. Any notice, request or other communication required or permitted hereunder shall be in writing and shall be deemed to
have been duly given upon the earlier of (i) actual receipt, (ii) the date that is one business day after delivery to an express overnight courier service for internal United States deliveries, or the date that is three business days after delivery
to an internationally recognized courier for deliveries across international borders, fees prepaid, as follows: 
  
 (a) if to an Investor, at such Investor’s respective address as set forth on Exhibit A hereto. 
  
 (b) if to the Company, at 3003 N. First Street, Suite 236,
San Jose, CA 95134, Attn. Ken Lee (with a copy to Barry J. Kramer, Esq. and Michael J. Patrick, Esq., Fenwick & West LLP, Two Palo Alto Square, Palo Alto, CA 94306). 
  
 Any party hereto (and such party’s permitted assigns) may by notice so given change its address for future notices
hereunder. 
  
 6.2 Entire Agreement. This
Agreement, together with all the Exhibits hereto, constitutes and contains the entire agreement and understanding of the parties with respect to the subject matter hereof and supersedes the Prior Series 1 Rights Agreement, the Prior Series A Rights
Agreement and any and all prior negotiations, correspondence, agreements, understandings, duties or obligations between the parties respecting the subject matter hereof. 
  
 6.3 Governing Law. This Agreement shall be governed by and construed exclusively in accordance with
the internal laws of the State of California as applied to agreements among California residents entered into and to be performed entirely within California, excluding that body of law relating to conflict of laws and choice of law. 
  
 6.4 Severability. If one or more provisions of this
Agreement are held to be unenforceable under applicable law, then such provision(s) shall be excluded from this Agreement and the balance of this Agreement shall be interpreted as if such provision(s) were so excluded and shall be enforceable in
accordance with its terms. 
  
 6.5 Third
Parties. Nothing in this Agreement, express or implied, is intended to confer upon any person, other than the parties hereto and their successors and assigns, any rights or remedies under or by reason of this Agreement. 
  
 6.6 Successors And Assigns. Subject to the provisions
of Section 4.1, the provisions of this Agreement shall inure to the benefit of, and shall be binding upon, the successors and permitted assigns of the parties hereto. 
  

 19. 

 6.7 Captions. The captions to sections of this Agreement have been inserted for
identification and reference purposes only and shall not be used to construe or interpret this Agreement. 
  
 6.8 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. 
  
 6.9 Costs And Attorneys’ Fees. In the event that any action, suit or other proceeding is instituted concerning or arising out of this Agreement or any transaction contemplated hereunder, the prevailing party shall recover all of
such party’s reasonable costs and attorneys’ fees incurred in each such action, suit or other proceeding, including any and all appeals or petitions therefrom. 
  
 6.10 Adjustments for Stock Splits, Etc. Wherever in this Agreement there is a reference to a specific
number of shares of Common Stock or Preferred Stock of the Company of any class or series, then, upon the occurrence of any subdivision, combination or stock dividend of such class or series of stock after the Effective Date, the specific number of
shares so referenced in this Agreement shall automatically be proportionally adjusted to reflect the affect on the outstanding shares of such class or series of stock by such subdivision, combination or stock dividend. 
  
 6.11 Aggregation of Stock. All shares held or
acquired by affiliated entities or persons shall be aggregated together for the purpose of determining the availability of any rights under this Agreement. 
  
 6.12 Prior Rights Agreements Superseded. Pursuant to Section 9 of the Prior Series A Rights Agreement, the undersigned parties who
are parties to such Prior Series A Rights Agreement hereby amend and restate the Prior Series A Rights Agreement to read in its entirety as set forth in this Agreement, all with the intent and effect that the Prior Series A Rights Agreement shall
hereby be terminated and entirely replaced and superseded by this Agreement. Pursuant to Section 5.3 of the Prior Series 1 Rights Agreement, the Series 1 Investor (who holds 100% of the outstanding shares of Series 1 Stock) hereby amends and
restates the Prior Series 1 Rights Agreement to read in its entirety as set forth in this Agreement, all with the intent and effect that the Prior Series 1 Rights Agreement shall hereby be terminated and entirely replaced and superceded by this
Agreement. 
  
 6.13 Waiver of Series 1 Right
of First Refusal. All rights of the Series 1 Investor under Section 3 of the Prior Series 1 Rights Agreement to purchase any of the shares of Series B Stock that are being sold by the Company pursuant to the Series B Agreement are hereby waived.

  
 [Remainder of this page has been intentionally left blank.]

  

 20. 

 IN WITNESS WHEREOF, the parties hereto have executed this agreement as of the date and year first
written above. 
  

			
	 THE COMPANY:
  
 LEADIS TECHNOLOGY, INC.

		
	By:	 	 /s/ Sung Tae Ahn

	 	 	

	 	 	 Sung Tae Ahn
 President and Chief Executive Officer

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

					
	 U.S. VENTURE PARTNERS VIII, L.P.
 USVP VIII AFFILIATES FUND, L.P.
 USVP ENTREPRENEUR PARTNERS VIII-A, L.P.
 USVP ENTREPRENEUR PARTNERS VIII-B, L.P.

		
	 By:
	 	 Presidio Management Group VIII, L.L.C.
 The General Partner of Each

			
	 	 	By:	 	 /s/ Michael P. Maher

	 	 	 	 	

	 	 	 Name:
	 	 Michael P. Maher

	 	 	 Its:
	 	 Attorney-in-Fact

		
	 Address:
	 	 2735 Sand Hill Road

	 	 	 Menlo Park, CA 94025

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

					
	PACVEN WALDEN VENTURES V, L.P.
		
	 By:
	 	 Pacven Walden Management V, Co., Ltd.
 As General Partner of
 Pacven Walden Ventures V, L.P.

			
	 	 	By:	 	 /s/ Lip-Bu Tan

	 	 	 	 	

	 	 	 Name:
	 	 Lip-Bu Tan

	 	 	 Its:
	 	 Director

		
	 Address:
	 	 One California Street, Suite 2800

	 	 	 San Francisco, CA 94111

  

					
	PACVEN WALDEN VENTURES PARALLEL V-A C.V.
		
	 By:
	 	 Pacven Walden Management V, Co., Ltd.
 As General Partner of
 Pacven Walden Ventures Parallel V-A C.V.

			
	 	 	By:	 	 /s/ Lip-Bu Tan

	 	 	 	 	

	 	 	 Name:
	 	 Lip-Bu Tan

	 	 	 Its:
	 	 Director

		
	 Address:
	 	 One California Street, Suite 2800

	 	 	 San Francisco, CA 94111

  

					
	PACVEN WALDEN VENTURES PARALLEL V-B C.V.
		
	 By:
	 	 Pacven Walden Management V, Co., Ltd.
 As General Partner of
 Pacven Walden Ventures Parallel V-B C.V.

			
	 	 	By:	 	 /s/ Lip-Bu Tan

	 	 	 	 	

	 	 	 Name:
	 	 Lip-Bu Tan

	 	 	 Its:
	 	 Director

		
	 Address:
	 	 One California Street, Suite 2800

	 	 	 San Francisco, CA 94111

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

					
	 PACVEN WALDEN VENTURES V
 ASSOCIATES FUND, L.P.

		
	 By:
	 	 Pacven Walden Management V, Co., Ltd.
 As General Partner of Pacven Walden
 Ventures V Associates Fund, L.P.

			
	 	 	By:	 	 /s/ Lip-Bu Tan

	 	 	 	 	

	 	 	 Name:
	 	 Lip-Bu Tan

	 	 	 Its:
	 	 Director

		
	 Address:
	 	 One California Street, Suite 2800

	 	 	 San Francisco, CA 94111

  

					
	 PACVEN WALDEN VENTURES V-QP
 ASSOCIATES FUND, L.P.

		
	 By:
	 	 Pacven Walden Management V, Co., Ltd.
 As General Partner of Pacven Walden
 Ventures V-QP Associates Fund, L.P.

			
	 	 	By:	 	 /s/ Lip-Bu Tan

	 	 	 	 	

	 	 	 Name:
	 	 Lip-Bu Tan

	 	 	 Its:
	 	 Director

		
	 Address:
	 	 One California Street, Suite 2800

	 	 	 San Francisco, CA 94111

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

			
	 F&W INVESTMENTS LLC – SERIES 2001

		
	By:	 	 /s/ Matthew P. Quilter

	 	 	

	 	 	 Matthew P. Quilter

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Ampoc Far East Co. Ltd.

	

	 Print Name of Investor

	
	 /s/ Ronald S. Su

	

	 Signature of Investor or Authorized Signatory

	
	  
	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Won Sang Moon

	

	 Print Name of Investor

	
	 /s/ Won Sang Moon

	

	 Signature of Investor or Authorized Signatory

	
	  
	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Park, Sahng Kyoo

	

	 Print Name of Investor

	
	 /s/ Sahng Kyoo Park

	

	 Signature of Investor or Authorized Signatory

	
	  
	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

									
	(individual signature block):	 	 	 	(entity signature block):
			
	 	 	 	 	 
	 	 	 	 	 	

	 	 	 	 	 	 	 	 	(print/type complete name of entity)
				
	/s/ J. Kim	 	 	 	By:	 	 
	
	 	 	 	 	 	

	 	 	(signature)	 	 	 	 	 	(signature)
					
	 Name:
	 	 Jihee Kim
	 	 	 	Name:	 	 
	 	 	
	 	 	 	 	 	

	 	 	(please print or type full name)	 	 	 	 	 	(please print or type full name)
					
	 	 	 	 	 	 	Title:	 	 
	 	 	 	 	 	 	 	 	

	 	 	(please print or type full name)	 	 	 	 	 	(please print or type full name)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Sung Tae Ahn

	

	 Print Name of Investor

	
	 /s/ Sung Tae Ahn

	

	 Signature of Investor or Authorized Signatory

	
	  
	

	 Name and Title of Authorized Signatory (if applicable)

  

 INVESTORS: 
  

	
	
	 Ronald S. Su/Ampoc

	

	 Print Name of Investor

	
	 /s/ Ronald S. Su

	

	 Signature of Investor or Authorized Signatory

	
	  
	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Ching Hui Chen

	

	 Print Name of Investor

	
	 /s/ Ching Hui Chen

	

	 Signature of Investor or Authorized Signatory

	
	  
	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Huang, Chi Jui

	

	 Print Name of Investor

  

	
	 
	
	 /s/ Huang, Chi Jui

	

	 Signature of Investor or Authorized Signatory

	
	 
	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Khodi Family Trust u/A/d 2/19/00

	

	 Print Name of Investor

  

	
	 
	
	 /s/ Parviz Kevin Khodi

	

	 Signature of Investor or Authorized Signatory

	
	 /s/ Parviz Kevin Khodi, Trustee

	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Eungu Kim

	

	 Print Name of Investor

  

	
	 
	
	 /s/ Eungu Kim

	

	 Signature of Investor or Authorized Signatory

	
	 
	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Yong Won Kwon

	

	 Print Name of Investor

  

	
	 
	
	 /s/ Yong Won Kwon

	

	 Signature of Investor or Authorized Signatory

	
	 
	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Lim, Ruger and Kim LLP

	

	 Print Name of Investor

  

	
	 
	
	 /s/ Brian King Sheldon

	

	 Signature of Investor or Authorized Signatory

	
	 Brian King Sheldon, Partner

	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Gary Liu

	

	 Print Name of Investor

  

	
	 
	
	 /s/ Gary Liu

	

	 Signature of Investor or Authorized Signatory

	
	 
	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Ronald S. Su

	

	 Print Name of Investor

  

	
	 
	
	 /s/ Ronald S. Su

	

	 Signature of Investor or Authorized Signatory

	
	 
	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Yueh-Chen Tseng

	

	 Print Name of Investor

  

	
	 
	
	 /s/ Yueh-Chen Tseng

	

	 Signature of Investor or Authorized Signatory

	
	 
	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 INVESTORS: 
  

	
	
	 Silicon Image

	

	 Print Name of Investor

  

	
	 
	
	 /s/ Robert G. Gargus

	

	 Signature of Investor or Authorized Signatory

	
	 Robert G. Gargus, CFO

	

	 Name and Title of Authorized Signatory (if applicable)

  

 [SIGNATURE PAGE TO LEADIS
TECHNOLOGY, INC. INVESTORS’ RIGHTS AGREEMENT] 

 Exhibit A 
  
 List of Investors 
  
 Series A Investors 
  

			
	 Seong Jin Ahn
 1181 Elmsford Court
 Cupertino, CA 95014
	 	 Yongwon Kwon
 15F, Kosmo Tower
 1002 Daechi-dong
 Gangnam-gu
 Seoul, 135-280 Korea

		
	 Sung Tae Ahn
 c/o Leadis Technology, Inc.
 3003 N. First St., Suite 236
 San Jose, CA 95134
	 	 Hae-Seung Lee
 63 Notre Dame Rd
 Bedford, MA 01730

		
	 AMPOC Far-East Co., Ltd.
 17F, No. 171 Sung-Teh
Road
 Taipei, Taiwan, R.O.C.
 Ann: Ronald Su
	 	 Lim, Ruger & Kim
 1055 W. 7th St., Suite 2800
 Los Angeles, CA
90017
 Attn: John S.C. Lim

		
	 Ching Hui Chen
 7F, No. 55 Peiyang St.
 Hsinchu, Taiwan 300, R.O.C.
	 	 Gary Liu
 5F, 12, Jen-Ai Rd. Sec. 2
 Taipei, Taiwan, R.O.C.

		
	 eSource Global, Inc.
 17 West 54th Street, I-F

New York, NY 10019
 Attn: John Koh, CEO
	 	 Won-Sang Moon
 Suite 703, City Air Terminal
Bldg.
 159-6 Samsung-dong
 Kangnam-ku
 Seoul, Korea

		
	 Chi Jui Huang
 5F, 12, Jen-Ai Rd., Sec. 2
 Taipei, Taiwan, R.O.C.
	 	 Shang Zyoo Park
 Unit 407-408, 4th Floor
 New East Ocean Centre
 9 Science Museum Road
 Tsimshatsui East
 Kln. Hong Kong

		
	 Khodi Family Trust U/A/dtd 2/19/00
 10403 Noel
Avenue
 Cupertino, CA 95014
 Attn: Parvis Khodi,
Trustee
	 	 Ronald S. Su
 c/o Ampoc Far East Co., Ltd.
 17 F., No. 171 Sung-Teh Rd
 Taipei, Taiwan, R.O.C.

		
	 Eungu Kim
 444 San Antonio Road, #10B
 Palo Alto, CA 94306
	 	 Yueh-Chen Tseng
 6F-7, No. 472, Sec. I
 Kuang Fu Rd.
 Hsin-Chu, Taiwan, R.O.C.

		
	 Jihee Kim
 457 Homer Ave.
 Palo Alto, CA 94301
	 	 

  

 1 of 3 

 List of Investors (continued) 
  
 Series 1 Investor 
  

			
	 Silicon Image, Inc.
 1060 E. Arques Ave.
 Sunnyvale, CA 94086
 Attn: David D. Lee, CEO
	 	 

  

 2 of 3 

 List of Investors (continued) 
  
 Series B Investors 
  

			
	 US Venture Partners VIII, L.P.
 2735 Sand Hill
Road
 Menlo Park CA 94025
 Attn: Michael Maher
  
 (a “USVP Affiliated Investor”)
	 	 Pacven Walden Ventures V Associates Fund, L.P.
 One
California Street, Suite 2800
 San Francisco, CA 94111
 Attn:
Lip-Bu Tan
  
 (a “Walden International Affiliated
Investor”)

		
	 USVP VIII Affiliates Fund, L.P.
 2731 Sand Hill
Road
 Menlo Park CA 94025
 Attn: Michael Maher
  
 (a “USVP Affiliated Investor”)
	 	 Pacven Walden Ventures V-QP Associates Fund, L.P.
 One
California Street, Suite 2800
 San Francisco, CA 94111
 Attn:
Lip-Bu Tan
  
 (a “Walden International Affiliated
Investor”)

		
	 USVP Entrepreneur Partners VIII-A, L.P.
 2735 Sand Hill
Road
 Menlo Park CA 94025
 Attn: Michael Maher
  
 (a “USVP Affiliated Investor”)
	 	 F&W Investments LLC-Series 2001
 c/o Fenwick &
West LLP
 Two Palo Alto Square
 Palo Alto, CA 94306
 Attn: Laird H. Simons III

		
	 USVP Entrepreneur Partners VIII-B, L.P.
 2735 Sand Hill
Road
 Menlo Park CA 94025
 Attn: Michael Maher
  
 (a “USVP Affiliated Investor”)
	 	 Ampoc Far-East Co., Ltd.
 17 F., No. 171, Sung-Teh
Road
 Taipei, Taiwan, R.O.C.
 Attn: Hank Hou

		
	 Pacven Walden Ventures V, L.P.
 One California Street,
Suite 2800
 San Francisco. CA 94111
 Attn Lip-Bu Tan

 
 (a “Walden International Affiliated Investor”)
	 	 Won Sang Moon
 Suite 703, City Air Terminal
Building
 159-6 Samsung-dong, Kangnam-ku
 Seoul,
Korea

		
	 Pacven Walden Ventures Parallel V-A CV.
 One California
Street, Suite 2800
 San Francisco, CA 94111
 Attn: Lip-Bu
Tan
  
 (a “Walden International Affiliated Investor”)
	 	 Sahng Kyoo Park
 Unit 407-408, 4th Floor, New East Ocean
Centre
 9 Science Museum Road
 Tsimshatsui East
 Kln. Hong Kong

		
	 Pacven Walden Ventures Parallel V-B C.V.
 One California
Street, Suite 2800
 San Francisco, CA 94111
 Attn: Li-Bu
Tan
  
 (a “Walden International Affiliated Investor”)
	 	 Jihee Kim
 457 Horner Avenue
 Palo Alto, CA 94301

  

 3 of 3Prepared by R.R. Donnelley Financial -- Warrant to purchase 50,000 shares of common stock

 Exhibit 4.4 
  

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT’),
OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO
REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. 
  
 WARRANT TO PURCHASE COMMON STOCK 
  
 OF 
  
 LEADIS TECHNOLOGY, INC. 
  
 Leadis Technology, Inc., a Delaware corporation (the “Company”), and Silicon Image, Inc., a Delaware corporation (the
“Investor”) are parties to that certain Technology License and Development Agreement dated as of October 6, 2000 (the “License Agreement”). This certifies that in consideration of the grant by the
Investor to the Company of licenses to certain Investor technology under the License Agreement, receipt of which is hereby acknowledged, the Investor is entitled, subject to the terms and conditions of this Warrant, to purchase from the Company at
any time prior to 5:00 p.m. Pacific time on October 31, 2007 (the “Expiration Date”) up to fifty thousand (50,000) shares of the Company’s Common Stock (the “Warrant Stock”), at the price of $0.15
per share (the “Warrant Price”) upon surrender of this Warrant at the principal office of the Company, together with a duly executed subscription in the form attached hereto as Exhibit 1 and (unless there is a net
exercise of this Warrant) simultaneous payment of the full Warrant Price therefor in lawful money of the United States as provided herein. The Warrant Price and the number and character of shares of Warrant Stock purchasable hereunder are subject to
adjustment as provided herein. Unless the context otherwise requires, the term “Warrant Stock” shall mean and include the stock and other securities and property at any time receivable or issuable upon exercise of this Warrant. The term
“Warrant” as used herein, shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein. 
  
 This Warrant is issued pursuant to that certain Series 1 Preferred Stock and Common Stock Warrant Purchase Agreement dated as of October 6, 2000 (the
“Purchase Agreement”), by and between the Company and the Investor, and is subject to the provisions thereof. 
  
 1. Definitions. The following definitions shall apply for purposes of this Warrant: 
  
 “Change of Control” is the
consummation of (i) a reorganization, consolidation or merger (or similar transaction or series of transactions) of the Company with or into any other corporation or corporations in which the holders of the Company’s outstanding shares
immediately before such transaction or series of related transactions do not, immediately after such transaction or series of related transactions, retain stock representing a majority of the voting power of the surviving corporation (or its parent
corporation if the surviving corporation is wholly owned by the parent corporation) of such transaction or series of related transactions, (ii) a transaction or series of transactions involving the transfer of stock representing a majority of the
voting power of the Company, or (iii) a sale of all or substantially all of the assets of the Company. 
  

 1. 

 “Company” means the Company (as defined above) and includes any
corporation which shall succeed to or assume the obligations of the Company under this Warrant. 
  
 “Holder” means any person who shall at the time be the registered holder of this Warrant. 
  
 “IPO” means the initial public
offering of the Company’s capital stock. 
  
 2.
Notice to Investor. If the Company proposes at any time to effect a Change of Control, the Company shall mail to the Holder a notice specifying the other parties involved, amount and character of consideration involved and date on
which the Change of Control is anticipated to become effective, which notice must be delivered to the Holder (i) no later than five (5) business days after the Company enters into definitive negotiations for a Change of Control or a letter of
intent, memorandum of understanding, agreement in principle, acquisition agreement or other similar agreement relating to a Change of Control and (ii) no later than twenty (20) business days prior to such anticipated effective date. If the Company
proposes at any time to file a registration statement under the Securities Act of 1933, as amended (the “1933 Act”), for the IPO, the Company shall mail to the Holder a notice specifying the date on which the filing with the
Securities and Exchange Commission (“SEC”) is expected to occur, which notice must be delivered to the Holder no later than ten (10) business days prior to such expected filing date. 
  
 3. Exercise. 
  
 3.1 Right to Exercise. The Investor shall only be
entitled to exercise this Warrant upon the earlier to occur of the following: (a) completion of development of the Reference Module (as defined in the License Agreement); (b) the filing by the Company of a registration statement under the 1933 Act
with the SEC for the IPO; or (c) the Company entering into any letter of intent, memorandum of understanding, agreement in principle, acquisition agreement or other similar agreement relating to a Change of Control. 
  
 3.2 Method of Exercise. Subject to the terms and
conditions of this Warrant, the Holder may exercise this Warrant in whole or in part, at any time before the Expiration Date by surrendering this Warrant at the principal offices of the Company, with the subscription form attached hereto duly
executed by the Holder, and payment in full of the Warrant Price or adjusted Warrant Price therefor, if applicable (as determined in accordance with the terms hereof) for the Warrant Stock to be purchased upon such exercise of this Warrant.

  
 3.3 Form of Payment. Payment may be
made by a check payable to the Company’s order or wire transfer of funds to the Company. 
  
 3.4 No Fractional Shares. No fractional shares may be issued upon any exercise of this Warrant, and any fractions shall be rounded
down to the nearest whole number of shares. If upon any exercise of this Warrant a fraction of a share results, the Company will pay the cash value of any such fractional share, calculated on the basis of the Warrant Price. 
  
 3.5 Net Exercise Election. The Holder may elect to
convert this Warrant, without the payment by the Holder of any additional consideration, by the surrender of this Warrant to the Company, with the net exercise election selected in the subscription form attached hereto duly executed by the Holder,
into the number of shares of Warrant Stock that is obtained under the following formula: 
  
 X = Y (A-B) 
               A 
  

 2. 

			
	where	  	X = the number of shares of Warrant Stock to be issued to the Holder pursuant to this Section 3.5.
		
	 	  	Y = the full number of shares of Warrant Stock that would have been issuable upon exercise of this Warrant pursuant to Sections 3.1 through 3.4 at the time the net exercise election is made
pursuant to this Section 3.5
		
	 	  	A = the fair market value of one share of Warrant Stock as of the time the net exercise election is made pursuant to this Section 3.5, as determined in good faith by the Company’s Board
of Directors (if the Warrant Stock is not publicly traded) or as reported in the Wall Street Journal (if the Warrant Stock is publicly traded).
		
	 	  	B = the Warrant Price.

  
 The
Company will promptly respond in writing to an inquiry by the Holder as to the then current fair market value of one share of Warrant Stock. 
  
 4. Issuance of Stock. This Warrant shall be deemed to have been exercised immediately prior to the close of business on the date of
its surrender for exercise as provided above, and the person entitled to receive the shares of Warrant Stock issuable upon such exercise shall be treated for all purposes as the holder of record of such shares as of the close of business on such
date. As soon as practicable on or after such date, the Company shall issue and deliver to the person or persons entitled to receive the same a certificate or certificates for the number of whole shares of Warrant Stock issuable upon such exercise.

  
 5. Adjustment Provisions. The number and
character of shares of Warrant Stock issuable upon exercise of this Warrant (or any shares of stock or other securities or property at the time receivable or issuable upon exercise of this Warrant) and the Warrant Price therefor, are subject to
adjustment upon the occurrence of the following events between the date this Warrant is issued and the date it is exercised: 
  
 5.1 Adjustment for Stock Splits, Stock Dividends, Recapitalizations, etc. The Warrant Price of this Warrant and the number of
shares of Warrant Stock issuable upon exercise of this Warrant (or any shares of stock or other securities at the time issuable upon exercise of this Warrant) shall each be proportionally adjusted to reflect any stock dividend, stock split, reverse
stock split, combination of shares, reclassification, recapitalization or other similar event affecting the number of outstanding shares of Warrant Stock (or such other stock or securities). 
  
 5.2 Adjustment for Other Dividends and Distributions.
In case the Company shall make or issue, or shall fix a record date for the determination of eligible holders entitled to receive, a dividend or other distribution payable respect to the Warrant Stock that is payable in (a) securities of the Company
(other than issuances with respect to which adjustment is required to be made under Section 5.1 (e.g., a stock split effected by means of a stock dividend)), or (b) assets (other than cash dividends paid or payable solely out of retained earnings),
then, and in each such case, the Holder, upon exercise of this Warrant at any time after the consummation, effective date or record date of such event, shall receive, in addition to the shares of Warrant Stock issuable upon such exercise prior to
such date, the securities or such other assets of the Company to which the Holder would have been entitled upon such date if the Holder had exercised this Warrant immediately prior thereto (all subject to further adjustment as provided in this
Warrant). 
  
 5.3 Adjustment for
Reorganization, Consolidation, Merger. In case of any reorganization of the Company (or of any other corporation, the stock or other securities of which are at 

  

 3. 

 
the time receivable on the exercise of this Warrant), after the date of this Warrant, or in case, after such date, the Company (or any such corporation)
shall consolidate with or merge into another corporation or convey all or substantially all of its assets to another corporation, then, and in each such case, the Holder, upon the exercise of this Warrant (as provided in Section 3), at any time
after the consummation of such reorganization, consolidation, merger or conveyance, shall be entitled to receive, in lieu of the stock or other securities and property receivable upon the exercise of this Warrant prior to such consummation, the
stock or other securities or property to which the Holder would have been entitled upon the consummation of such reorganization, consolidation, merger or conveyance if the Holder had exercised this Warrant immediately prior thereto, all subject to
further adjustment as provided in this Warrant, and the successor or purchasing corporation in such reorganization, consolidation, merger or conveyance (if other than the Company) shall duly execute and deliver to the Holder a supplement hereto
acknowledging such corporation’s obligations under this Warrant; and in each such case, the terms of this Warrant shall be applicable to the shares of stock or other securities or property receivable upon the exercise of this Warrant after the
consummation of such reorganization, consolidation, merger or conveyance. 
  
 5.4 Conversion of Stock. In case all the authorized Warrant Stock of the Company is converted, pursuant to the Company’s Certificate of Incorporation, into other securities or property, or the Warrant
Stock otherwise ceases to exist, then, in such case, the Holder, upon exercise of this Warrant at any time after the date on which the Warrant Stock is so converted or ceases to exist (the “Termination Date”), shall receive,
in lieu of the number of shares of Warrant Stock that would have been issuable upon such exercise immediately prior to the Termination Date (the “Former Number of Shares of Warrant Stock”), the stock and other securities and
property to which the Holder would have been entitled to receive upon the Termination Date if the Holder had exercised this Warrant with respect to the Former Number of Shares of Warrant Stock immediately prior to the Termination Date (all subject
to further adjustment as provided in this Warrant). 
  
 5.5 Notice of Adjustments. The Company shall promptly give written notice of each adjustment or readjustment of the Warrant Price or the number of shares of Warrant Stock or other securities issuable upon exercise of this Warrant.
The notice shall describe the adjustment or readjustment and show in reasonable detail the facts on which the adjustment or readjustment is based. 
  
 5.6 No Change Necessary. The form of this Warrant need not be changed because of any adjustment in the Warrant Price or in the
number of shares of Warrant Stock issuable upon its exercise. 
  
 5.7 Reservation of Stock. If at any time the number of shares of Warrant Stock or other securities issuable upon exercise of this Warrant shall not be sufficient to effect the exercise of this Warrant, the
Company will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Warrant Stock or other securities issuable upon exercise of this Warrant as shall be sufficient for such
purpose. 
  
 6. No Rights or Liabilities as
Stockholder. This Warrant does not by itself entitle the Holder to any voting rights or other rights as a stockholder of the Company. In the absence of affirmative action by the Holder to purchase Warrant Stock by exercise of this Warrant,
no provisions of this Warrant, and no enumeration herein of the rights or privileges of the Holder, shall cause the Holder to be a stockholder of the Company for any purpose. 
  
 7. No Impairment. The Company will not, by amendment of its Certificate of Incorporation or Bylaws, or
through reorganization, consolidation, merger, dissolution, issue or sale of securities, sale of assets or any other voluntary action, willfully avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at
all times in good faith assist in the carrying 

  

 4. 

 
out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the Holder against wrongful
impairment. Without limiting the generality of the foregoing, the Company will take all such action as may be necessary or appropriate in order that the Company may duly and validly issue fully paid and nonassessable shares of Warrant Stock upon the
exercise of this Warrant. 
  
 8. Attorneys’
Fees. In the event any party is required to engage the services of any attorneys for the purpose of enforcing this Warrant, or any provision thereof, the prevailing party shall be entitled to recover its reasonable expenses and costs in
enforcing this Warrant, including attorneys’ fees. 
  
 9.
Transfer. The Investor may transfer this Warrant and its rights hereunder to a third party upon notice given to the Company. The rights and obligations of the Company and the Holder under this Warrant shall be binding upon and
benefit their respective permitted successors, assigns, heirs, administrators and transferees. 
  
 10. Governing Law. This Warrant shall be governed by and construed under the internal laws of the State of California as applied to agreements among California residents entered into and to be
performed entirely within California, without reference to principles of conflict of laws. 
  
 11. Headings. The headings and captions used in this Warrant are used for convenience only and are not to be considered in construing or interpreting this Warrant. All references in this Warrant
to sections and exhibits shall, unless otherwise provided, refer to sections hereof and exhibits attached hereto, all of which exhibits are incorporated herein by this reference. 
  
 12. Notices. Unless otherwise provided, any notice required or permitted under this Warrant shall be
given in writing and shall be deemed effectively given upon personal delivery to the party to be notified or upon deposit with the United States Post Office, by registered or certified mail, postage prepaid and addressed to the Holder at the last
address furnished to the Company by the Holder in writing or, in the case of the Company, at the principal offices of the Company, or at such other address as the Holder or the Company may designate by giving ten (10) days’ advance written
notice to the other party. 
  
 13. Amendment;
Waiver. Any term of this Warrant may be amended, and the observance of any term of this Warrant may be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the
Company and the Holder. Any amendment or waiver effected in accordance with this Section shall be binding upon the Holder, each future holder of such securities, and the Company. 
  
 14. Severability. If one or more provisions of this Warrant are held to be unenforceable under
applicable law, such provision(s) shall be excluded from this Warrant and the balance of the Warrant shall be interpreted as if such provision(s) were so excluded and shall be enforceable in accordance with its terms. 
  
 15. Terms Binding. By acceptance of this Warrant, the
Holder accepts and agrees to be bound by all the terms and conditions of this Warrant. 
  
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 
  

 5. 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be signed in its name as of the date
set forth below. 
  
 Dated: October 31, 2000 
  

			
	THE COMPANY:
	
	 LEADIS TECHNOLOGY, INC.

		
	 By:
	 	 /s/ Sung Tae Ahn

	 	 	

	 Name:
	 	 Sung Tae Ahn

	 Title:
	 	 CEO

  

			
	
	 AGREED AND ACKNOWLEDGED:

	
	THE HOLDER:
	
	 SILICON IMAGE, INC.

		
	 By:
	 	 /s/

	 	 	

	 Name:
	 	 David D. Nell

	 Title:
	 	 Chief Executive Officer

  
 Exhibit 1: Form of Subscription

  
 [SIGNATURE PAGE TO WARRANT] 
  

 IN WITNESS WHEREOF, the Company has caused this Warrant to be signed in its name as of the date
set forth below. 
  
 Dated: October 31, 2000 
  

			
	THE COMPANY:
	
	 LEADIS TECHNOLOGY, INC.

		
	 By:
	 	 
	 	 	

	 Name:
	 	 Sung Tae Ahn

	 Title:
	 	 CEO

  

			
	
	 AGREED AND ACKNOWLEDGED:

	
	THE HOLDER:
	
	 SILICON IMAGE, INC.

		
	 By:
	 	 /s/ David D. Nell

	 	 	

	 Name:
	 	 David D. Nell

	 Title:
	 	 Chief Executive Officer

  
 Exhibit 1: Form of Subscription

  
 [SIGNATURE PAGE TO WARRANT] 
  

 Exhibit 1 
  

FORM OF SUBSCRIPTION 
 (To be
signed only upon exercise of Warrant) 
  

	To:	Leadis Technology, Inc. 

  
 (1) Method of Exercise (choose one): 
  
  ̈ Cash Exercise Election.
The undersigned Holder hereby elects to purchase              shares of Warrant Stock, pursuant to the terms of the attached Warrant, and tenders herewith payment of the purchase
price for such shares in full. 
  
  ̈ Net Exercise Election. The undersigned Holder elects to convert the Warrant into shares of Warrant Stock by net exercise election pursuant to
Section 3.5 of the Warrant. This conversion is exercised with respect to shares of Warrant Stock covered by the Warrant. 
  
 (2) Please issue a certificate or certificates representing such shares of Warrant Stock in the name or names specified below: 
  

					
			
	 	 	 	 	 
	
	 	 	 	

	(Name)	 	 	 	(Name)
			
	 	 	 	 	 
	
	 	 	 	

	(Address)	 	 	 	(Address)
			
	 	 	 	 	 
	
	 	 	 	

	(City, State, Zip Code)	 	 	 	(City, State, Zip Code)
			
	 	 	 	 	 
	
	 	 	 	

	(Federal Tax Identification Number)	 	 	 	(Federal Tax Identification Number)
			
	 	 	 	 	 
	
	 	 	 	

	(Date)	 	 	 	(Signature of Holder)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}]]